VUKOTIC, Ranka
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.601
EU - Europa 723
AS - Asia 517
SA - Sud America 15
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 3.865
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.592
SE - Svezia 188
SG - Singapore 173
GB - Regno Unito 167
CN - Cina 147
HK - Hong Kong 130
IT - Italia 100
DE - Germania 65
RU - Federazione Russa 42
FI - Finlandia 40
BG - Bulgaria 38
UA - Ucraina 20
ID - Indonesia 19
TR - Turchia 15
CZ - Repubblica Ceca 13
BR - Brasile 8
CA - Canada 8
NL - Olanda 6
RO - Romania 6
BE - Belgio 5
EG - Egitto 5
FR - Francia 5
LT - Lituania 5
AT - Austria 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
CH - Svizzera 3
IE - Irlanda 3
JP - Giappone 3
KR - Corea 3
MY - Malesia 3
PL - Polonia 3
VN - Vietnam 3
CO - Colombia 2
ES - Italia 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
IN - India 2
IR - Iran 2
PH - Filippine 2
QA - Qatar 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KW - Kuwait 1
NO - Norvegia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.865
Salva come PNG Salva come JPEG
Città #
Santa Clara 497
Fairfield 313
Chandler 302
Ashburn 216
Nyköping 157
Singapore 153
Houston 150
Hong Kong 128
Woodbridge 124
Cambridge 108
Southend 104
Wilmington 104
Seattle 95
San Diego 51
Ann Arbor 49
Dearborn 44
Princeton 41
Sofia 38
Helsinki 36
Jacksonville 30
Modena 27
Beijing 22
New York 22
Moscow 21
Jakarta 18
Shanghai 17
Redwood City 16
Izmir 13
Brno 12
Bremen 10
Nanjing 10
Falls Church 9
Grafing 9
Guangzhou 9
Kilburn 9
London 9
Wuhan 9
Augusta 8
Bologna 8
Chiswick 8
Eugene 8
Hounslow 6
Norwalk 6
Toronto 6
Brussels 5
Cairo 5
Munich 5
San Mateo 5
Brooklyn 4
Chicago 4
Des Moines 4
San Jose 4
São Paulo 4
Andover 3
Baotou 3
Berlin 3
Boardman 3
Buenos Aires 3
Dublin 3
Frankfurt am Main 3
Kuala Lumpur 3
Los Angeles 3
Santa Rosa 3
Vienna 3
Acton 2
Amsterdam 2
Athens 2
Belo Horizonte 2
Brasília 2
Budrio 2
Dong Ket 2
Fabriano 2
Falkenstein 2
Glendale 2
Hefei 2
Jinan 2
Kemerovo 2
Leawood 2
Lucca 2
Milan 2
Ottawa 2
Palermo 2
Phoenix 2
Sabbio Chiese 2
Salt Lake City 2
San Cesario di Lecce 2
Seongnam 2
Shenzhen 2
Tokyo 2
Wenzhou 2
Worthing 2
Zagreb 2
Zgierz 2
Amman 1
Ardabil 1
Bari 1
Baveno 1
Brandon 1
Brentford 1
Calcinaia 1
Totale 3.170
Salva come PNG Salva come JPEG
Nome #
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 253
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 238
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 213
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 192
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 191
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 189
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 187
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 164
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 95
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 93
Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C 92
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 88
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 87
Prospective, observational real-life study on eligibility for and outcomes of antiviral treatment with peginterferon α plus ribavirin in chronic hepatitis C 86
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 80
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 79
Hepatitis B virus and immune response 78
Clinical and serological profile of primary biliary cirrhosis in men 78
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 77
De novo autoimmune hepatitis in liver transplant: State-of-the-art review 74
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 73
Familial intrahepatic cholestasis: New and wide perspectives 71
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 70
Bone marrow derived stem cells for the treatment of end-stage liver disease 70
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group 69
The Effect of Liraglutide on β-Blockade for Preventing Variceal Bleeding: A Case Series 69
Insights into cancer severity from biomolecular interaction mechanisms 67
Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir? 66
Impact of psychosocial status on liver transplant process 66
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods 65
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 64
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 64
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 63
Hepatitis C Virus Core Antigen (HCVAg): An affordable assay to monitor the efficacy of treatment in DAAs era 63
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort 60
Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options 56
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 56
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 55
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 51
Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgery 47
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 33
Totale 3.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020166 0 0 0 0 0 0 67 31 30 16 15 7
2020/2021581 23 13 23 43 30 35 24 37 183 24 127 19
2021/2022726 58 30 40 40 16 51 23 87 83 77 123 98
2022/2023746 108 105 69 78 74 114 11 67 81 4 21 14
2023/2024455 21 25 27 70 102 21 43 47 5 6 21 67
2024/2025795 47 12 4 121 353 241 17 0 0 0 0 0
Totale 3.932